pharma · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · metastatic or unresectable, recurrent HNSCC
Createrna Science and
Wuhan Createrna Science and Technology Co., Ltd
Wuhan Createrna Science is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, metastatic or unresectable, recurrent HNSCC,
Company details
- Status
- Public
- HQ
- shanghai, CN, London
- Employees
- 26
- Programs
- 51
- Drugs
- 87
- Patents
- 0
Quick answer
Wuhan Createrna Science is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, metastatic or unresectable, recurrent HNSCC, Dry Eye Disease, Type 2 diabetes mellitus, Advanced cutaneous melanoma and Advanced mucosal melanoma. NovaPharmaNews links 51 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (30), phase 3 (13), approved (5).
Company snapshot
Createrna Science and maintains 51 tracked programs across Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, metastatic or unresectable, recurrent HNSCC, Dry Eye Disease, Type 2 diabetes mellitus, Advanced cutaneous melanoma and Advanced mucosal melanoma, Primary Immune Thrombocytopenia, Basket tumors, Burkitt lymphoma, Mantle cell lymphoma, Chronic Hepatitis B, Low back pain, newly diagnos
- 51 active pipeline program(s) linked via ClinicalTrials.gov.
- 51 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Createrna Science and. Not investment advice.
Top assets
Lead pipeline drugs
- approved
- Marketed / approved
- approved
- Marketed / approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for Createrna Science and.
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Createrna Science and.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Createrna Science and?
-
Is Createrna Science and publicly traded?
-
What drugs does Createrna Science and develop or market?
-
What are the latest developments for Createrna Science and?
-
What therapeutic areas does Createrna Science and focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.